Keith Meister, Corvex Management's chief investment officer, will join Illumina's board starting March 28. He's no stranger ...

Illumina expects to reach a growth rate in its revenues of 6%-9% CAGR by 2027. See why I think ILMN stock is an appealing ...

Activist investor Keith Meister will join the board of gene-sequencing maker Illumina, and current board member Scott ...

This writer shows how a relatively modest sum of money invested each month into growth stocks can result in a sizeable ...

Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Cramer looks at Illumina, Archer Aviation, NANO Nuclear Energy, Steris, Sixth Street Specialty Lending, Lam Research and Arista Networks.